Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horst Olschewski

Showing results (1-10 of 286) with videos related to

Pageof 29
Sort By:
Herz|October 9, 2002
[Drug therapy of primary and secondary pulmonary hypertension]Horst Olschewski
Pulmonary Circulation|September 30, 2016
Why we should care about the mysteries of pulmonary hypertensionHorst Olschewski
Pulmonary Circulation|October 28, 2025
How It Really Happened-the Development of Inhaled Iloprost for Pulmonary Arterial HypertensionHorst Olschewski
Der Pneumologe|November 24, 2020
[Introduction to the topic]Horst Olschewski
Pulmonary Circulation|September 13, 2017
Understanding exercise hemodynamicsHorst Olschewski
Respiration; International Review of Thoracic Diseases|June 13, 2015
Imatinib for Pulmonary Arterial Hypertension - Wonder Drug or Killer Drug?Horst Olschewski
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2006
[Pulmonary hypertension: the future has begun]Horst Olschewski
Diagnostics (Basel, Switzerland)|March 6, 2021
The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung DiseaseHorst Olschewski
Wiener Medizinische Wochenschrift (1946)|March 18, 2016
[Pulmonary embolism and direct oral anticoagulants]Horst Olschewski
Handbook of Experimental Pharmacology|October 5, 2013
ProstacyclinsHorst Olschewski
Pageof 29

Showing results (1-10 of 286) with videos related to

Sort By:
Pageof 29
Herz|October 9, 2002
[Drug therapy of primary and secondary pulmonary hypertension]Horst Olschewski
Pulmonary Circulation|September 30, 2016
Why we should care about the mysteries of pulmonary hypertensionHorst Olschewski
Pulmonary Circulation|October 28, 2025
How It Really Happened-the Development of Inhaled Iloprost for Pulmonary Arterial HypertensionHorst Olschewski
Der Pneumologe|November 24, 2020
[Introduction to the topic]Horst Olschewski
Pulmonary Circulation|September 13, 2017
Understanding exercise hemodynamicsHorst Olschewski
Respiration; International Review of Thoracic Diseases|June 13, 2015
Imatinib for Pulmonary Arterial Hypertension - Wonder Drug or Killer Drug?Horst Olschewski
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2006
[Pulmonary hypertension: the future has begun]Horst Olschewski
Diagnostics (Basel, Switzerland)|March 6, 2021
The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung DiseaseHorst Olschewski
Wiener Medizinische Wochenschrift (1946)|March 18, 2016
[Pulmonary embolism and direct oral anticoagulants]Horst Olschewski
Handbook of Experimental Pharmacology|October 5, 2013
ProstacyclinsHorst Olschewski
Pageof 29